C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/85 (2006.01) A01K 67/027 (2006.01) A61K 31/70 (2006.01) C07H 21/00 (2006.01) C07K 14/705 (2006.01) C12N 5/10 (2006.01) C12N 15/11 (2006.01) C12Q 1/68 (2006.01)
Patent
CA 2117756
2117756 9321309 PCTABS00027 Clones (SEQ ID NO:1, SEQ ID NO:2, and SEQ ID NO:3) have been isolated and sequenced. An antisense construct has been made from part of SEQ ID NO:1 that blocks opioid binding in cells and has been used to produce transgenic animals having a reduced sensitivity to narcotic analgesics. The oligonucleotide sequence introduced into the animals at an embryonic stage was the first about 500 base pairs, but was reversed in direction. Oligonucleotide constructs of the invention are also useful as probes or as therapeutic and diagnostic agents.
Lee Nancy M.
Lippman David
Loh Horace H.
Barrigar & Moss
Duz Partnership
LandOfFree
Oligonucleotide sequences and transgenic animals transfected... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotide sequences and transgenic animals transfected..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotide sequences and transgenic animals transfected... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1616097